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INTRODUCTION 
 
Cellular cardiomyoplasty is a promising therapy for patients with myocardial infarction (MI) [1]. 
Among the cell types studied, mesenchymal stem cells (MSCs) are regarded as the most practical 
cell source for clinical applications, as they can be readily isolated from the patients’ bone 
marrows. However, current procedures for cell transplantation through direct injection of 
trypsin-dissociated cells are frequently associated with a low retention rate of engrafted cells and 
a suboptimal consequence of cell survival and function [2]. To address this concern, a method 
employing a thermo-responsive methylcellulose (MC) hydrogel system, for the fabrication of 
cell sheet fragments of MSCs without applying proteolytic enzymes, was previously reported by 
our group [3]. Our results demonstrated that the harvested MSC sheet fragments retained 
endogenous extracellular matrix and offered a significantly higher cell retention rate following 
engraftment in a rat model, thus showing a better functional benefit for the infarcted heart when 
compared with dissociated MSCs [4]. In this study, a porcine model with surgically induced MI 
was used to evaluate the effectiveness of engraftment of cell sheet fragments of autologous bone 
marrow-derived MSCs on its post-infarcted cardiac function. Swine have been considered as an 
ideal large animal model for the clinical translation of cardiovascular research, due to their 
resemblance to human organ size and 
physiology. These translational studies in 
large animal models are necessary if the 
tremendous potential suggested by rat 
studies is to be realized clinically. 
 
EXPERIMENTAL METHODS 
 
Each pig was subjected to surgically 
induced MI, and its bone marrow was 
extracted simultaneously. The MSCs were 
then isolated, amplified and seeded on the 
surface of MC hydrogel system. After 
reaching confluence, a sterilized stainless 
screen was used to compress and fragment 
the grown MSC monolayer, resulting in  
Figure 1. Schematic illustration of the processes 
used for the fabrication of cell sheet fragments of 
bone marrow-derived MSCs for autologous 
cellular cardiomyoplasty. 
fragmented MSC sheets. Finally, the 
obtained MSC sheet fragments were 
collected for autologous intramyocardial 
transplantation (Fig. 1). The groups treated 
with saline or dissociated MSCs were used 
as controls. Cardiac functions were  
evaluated by echocardiography before MI, 
at 4 weeks after MI induction and at 4 
weeks post cell transplantation. Finally, 
animals were sacrificed, and the hearts 
were retrieved and processed for 
histological assessment. 
 
RESULTS AND DISCUSSION 
 
As indicated by the M-mode 
echocardiograms shown in Fig. 2, the 
dilation of left ventricle (LV) was 
significantly attenuated in the heart that 
received MSC sheet fragments when 
compared to the hearts treated with saline 
or dissociated MSCs (control groups). 
 
Gross pathologic examination revealed 
that the heart that received saline treatment 
exhibited severely transmural infarction 
with significantly anterior wall thinning 
and LV chamber enlargement (Fig. 3). Conversely, transplantation of MSC sheet fragments 
substantially reduced the ratio of LV occupied by fibrotic scar tissues, maintained LV wall 
thickness and prevented the global cardiac morphology from post-infarcted dilation. 
 
CONCLUSION 
 
These results suggest that transplantation of MSC sheet fragments in infarcted hearts can 
markedly attenuate the adverse ventricular dilation, preserving the cardiac function post MI, thus 
supporting the hypothesis that our approach holds promise to become a translational applicable 
strategy for autologous stem cell-based cardiac repair. 
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Figure 2. Representative traces of LV short-axis 
M-mode echocardiograms obtained at baseline (at 
4 weeks after MI induction) and at 4 weeks after 
treatment. 
Figure 3.  Representative histological cross-
sections that depicting the infarct zones of the 
hearts for all studied groups at 4 weeks after 
treatment. 
